Antibiotic use in the United States : 2021 update : progress and opportunities

Details

• Corporate Authors:
  National Center for Emerging and Zoonotic Infectious Diseases (U.S.)
• Description:
  The U.S. National Action Plan for Combatting Antibiotic-Resistant Bacteria directs federal agencies to accelerate the U.S. government’s response to antibiotic resistance by presenting coordinated, strategic actions to improve the health and well-being of all Americans across the One Health spectrum. The National Action Plan was first released in 2015 and includes national targets to combat antibiotic-resistant bacteria, specifically those recognized in CDC’s 2019 Antibiotic Resistance Threats Report. In late 2020, CDC joined with other federal partners in the CARB Task Force to release the next iteration of the National Action Plan, outlining ambitious goals and actions to be completed from 2020 through 2025 National Action Plan for Combating Antibiotic- Resistant Bacteria, 2020-2025 | ASPE (hhs.gov).
  
  Antibiotic Use in the United States, 2021 Update: Progress and Opportunities is a publication of the National Center for Emerging and Zoonotic Infectious Diseases within the Centers for Disease Control and Prevention.
  
  Suggested citation: CDC. Antibiotic Use in the United States, 2021 Update: Progress and Opportunities. Atlanta, GA: US Department of Health and Human Services, CDC; 2021.
  
  CS327090-A
  
  stewardship-report-2021-H.pdf
  
  
• Subjects:
  Anti-Infective Agents Antimicrobial Stewardship Drug Resistance, Bacterial Drug Resistance, Microbial Infection Control
• Document Type:
  Report
• Place as Subject:
  United States
• Pages in Document:
  25 numbered pages
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:7c2497b2af376267d50dda562cb28f3b45dcd5ed0b25c05126d591cbb80cd606
• Download URL:
  https://stacks.cdc.gov/view/cdc/111691/cdc_111691_DS1.pdf
• File Type:
  [PDF - 3.83 MB ]